Medicine

The new Omicron coronavirus strain may account for more than half of all COVID-19 cases in the European Union in the coming months. 

Symptoms of the Omicron coronavirus strain have so far been mild and similar to those of influenza.

A US Food and Drug Administration (FDA) advisory panel has recommended by a majority vote that Merck's anti-COVID-19 pills be approved.

Neurological complications are observed in 80% of those who suffered severe COVID-19 and were in the hospital.

Similar cases of infection have already been recorded in South Africa, Botswana, Hong Kong, Israel, Belgium, Germany, Great Britain, Australia, and the Czech Republic.

Director of the Center. Gamalei Alexander Gunzburg said he would test the effectiveness of the Sputnik V vaccine against the new COVID-19 strain from Botswana when he receives a sample.

To exclude the diagnosis, doctor advised to do a CT scan of the lungs for those who were sick with coronavirus, and for people over 55 years old.

Since there was one «delta» in Japan, mutations in the nsp14 protein accumulated in it, according to Japanese colleagues.

Currently, the main distributor of coronavirus is unvaccinated people.

The US may introduce the concepts of 'complete' and 'completed' vaccination levels once the country has gained sufficient experience with the products used for it.

Russia and Israel are discussing the recognition of COVID-19 vaccination certificates with the Russian vaccine "Sputnik Lite".

In Germany, 66 884 new cases of coronavirus were detected in the past 24 hours.

In Russia, a new rapid test for coronavirus is being developed, which will make it possible to find out in 15 minutes whether a person is sick or not.

The companies reported that their vaccine against COVID-19 is 100% effective for protecting children 12-15 years old.

Mortality has been reduced, among other things, thanks to the use of drugs that dilute the blood and relieve inflammation.